{"doi":"10.5649/jjphcs.37.631","title":"Analysis of Factors Influencing Discontinuation of Treatment and Development of Adverse Events with Sorafenib in Patients with Advanced Hepatocellular Carcinoma","abstract":null,"journal":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","year":2011,"id":26892,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":154515,"name":"Masahide Fukudo","orcid":null,"position":1,"is_corresponding":false},{"id":154516,"name":"Sachio Fukatsu","orcid":null,"position":2,"is_corresponding":false},{"id":154517,"name":"Ikuko Yano","orcid":null,"position":3,"is_corresponding":false},{"id":154518,"name":"Toshiya Katsura","orcid":null,"position":4,"is_corresponding":false},{"id":154514,"name":"Aya Shimogai","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24523987","pmcid":null,"openalex_id":"https://openalex.org/W2318402467","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.20455757,"influential_citations":0,"citation_trend":[],"oa_status":"bronze","license":null,"oa_locations":[{"url":"https://www.jstage.jst.go.jp/article/jjphcs/37/11/37_631/_pdf","host_type":"journal"},{"url":"https://www.jstage.jst.go.jp/article/jjphcs/37/11/37_631/_pdf","host_type":"BRONZE"},{"url":"https://www.jstage.jst.go.jp/article/jjphcs/37/11/37_631/_pdf","host_type":"publisher"},{"url":"https://doi.org/10.5649/jjphcs.37.631","host_type":"journal"}],"fields_of_study":["Colorectal Cancer Treatments and Studies","Hepatocellular Carcinoma Treatment and Prognosis","Multiple Myeloma Research and Treatments","Medicine","Biology"],"mesh_terms":[],"keywords":["Discontinuation","Sorafenib","Medicine","Adverse effect","Hepatocellular carcinoma","Internal medicine","Diarrhea","Surgery","Gastroenterology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T15:58:23.284394Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}